Get the latest news, insights, and market updates on KVUE (Kenvue Inc.). Explore the news page 1 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.
Kimberly-Clark Highlights Generational Value Creation Opportunity at 2026 CAGNY Conference
Kimberly-Clark Corporation (NASDAQ: KMB) today presented at the 2026 Consumer Analyst Group of New York (CAGNY) Conference, outlining how Kimberly-Clark's fast and agile operating model and differentiated capabilities position the company to benefit from growth trends in key cohorts, raise the standard of care and create generational value through its pending acquisition of Kenvue. Feb 19, 2026 - $KVUE
Kenvue Deal With Kimberly-Clark Puts Valuation And Dividend In Focus
Shareholders of Kenvue (NYSE:KVUE) have approved the company’s acquisition by Kimberly-Clark, with the deal now awaiting regulatory and closing conditions. Kimberly-Clark shareholders have also voted in favor of the transaction, aligning both sides on the proposed takeover structure. Kenvue has announced that Chief Financial Officer Amit Banati plans to depart following the completion of the acquisition, setting up a key leadership transition. Kenvue enters this phase of corporate change... Feb 19, 2026 - $KVUE
Kenvue tops Q4 forecasts as Kimberly-Clark deal advances
Kenvue Inc (NYSE:KVUE) reported fourth quarter results that topped Wall Street expectations, while the consumer health company also outlined restructuring steps ahead of its planned combination with Kimberly-Clark. For Q4, Kenvue posted adjusted earnings per share of $0.27, beating analyst... Feb 18, 2026 - $KVUE
Kimberly-Clark Kenvue Deal Progress Raises Integration And Debt Questions
Kimberly-Clark (NasdaqGS:KMB) is moving ahead with its planned acquisition of Kenvue as the consumer health company begins a global workforce reduction tied to the transaction. Kenvue's restructuring, including significant job cuts, is being positioned as preparation for integration with Kimberly-Clark. The deal process and related cost actions come as Kimberly-Clark's shares trade around $107.52. For you as an investor looking at Kimberly-Clark, the proposed Kenvue acquisition sits against... Feb 18, 2026 - $KVUE
Is Kenvue’s (KVUE) Profitability Strengthening Despite Softer Sales Altering The Investment Case For Kenvue (KVUE)?
Kenvue Inc. has reported its fourth-quarter 2025 results, with sales rising to US$3,780 million and net income reaching US$330 million, while full‑year sales eased to US$15.12 billion but net income increased to US$1.47 billion. The stronger earnings and higher earnings per share compared with the prior year, despite slightly lower annual sales, highlight Kenvue’s recent profitability improvement. We’ll now examine how this earnings outperformance, particularly the rise in full‑year net... Feb 18, 2026 - $KVUE
Is Kenvue (KVUE) Attractively Priced After Spin Off From Johnson & Johnson?
If you are wondering whether Kenvue's current share price lines up with its underlying value, you are not alone, this article breaks down what the market might be pricing in. The stock last closed at US$18.41, with returns of 0.5% over 7 days, 7.0% over 30 days, 6.3% year to date and a 12.7% decline over the past year, which gives a mixed picture of recent sentiment. Recent headlines have focused on Kenvue's position as a standalone consumer health company following its separation from... Feb 18, 2026 - $KVUE
Assessing Kenvue (KVUE) Valuation As Shares Sit Below Some Intrinsic Value Estimates
Event context and recent share performance Kenvue (KVUE) has been on investors’ radar after recent trading, with the stock closing at US$18.41 and showing mixed short term returns, including a 1.6% decline over the past day and a 12.7% decline over the past year. See our latest analysis for Kenvue. Looking beyond the latest move, Kenvue’s share price return has been positive over the past month and quarter, while its 1 year total shareholder return is still negative. This suggests recent... Feb 18, 2026 - $KVUE
We use cookies and similar technologies to collect and process data such as browsing activity or unique identifiers.
Selecting "Allow All" to help us understand site usage and improve the platform.
Choosing "Essential Cookies Only" enables only the cookies necessary for core site functions, such as staying logged in.
For more information, please see our Privacy Policy.
Continue with Google
Continue with Facebook
Continue with Microsoft
Continue with Apple